169 related articles for article (PubMed ID: 28724829)
1. Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment.
Storch MW; Hoerauf H
Indian J Ophthalmol; 2017 Jul; 65(7):632-633. PubMed ID: 28724829
[TBL] [Abstract][Full Text] [Related]
2. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
[TBL] [Abstract][Full Text] [Related]
4. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
Treumer F; Wienand S; Purtskhvanidze K; Roider J; Hillenkamp J
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
[TBL] [Abstract][Full Text] [Related]
6. High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration.
Lee DK; Kim SH; You YS; Kwon OW
Korean J Ophthalmol; 2016 Aug; 30(4):265-71. PubMed ID: 27478353
[TBL] [Abstract][Full Text] [Related]
7. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
[TBL] [Abstract][Full Text] [Related]
8. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC
Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
[TBL] [Abstract][Full Text] [Related]
9. Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degeneration.
Au A; Parikh VS; Singh RP; Ehlers JP; Yuan A; Rachitskaya AV; Sears JE; Srivastava SK; Kaiser PK; Schachat AP; Martin DF; Modi Y
Br J Ophthalmol; 2017 Jul; 101(7):970-975. PubMed ID: 27913442
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal anti-VEGF therapy for vascularized pigment epithelium detachment in age-related macular degeneration.
Giansanti F; Bacherini D; Giacomelli G; Virgili G; Finocchio L; Fiore T; Vannozzi L; Menchini U
Eur J Ophthalmol; 2014; 24(3):402-8. PubMed ID: 24242217
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab simultaneous combined with dexamethasone implant for treatment of neovascular serous retinal pigment epithelial detachment secondary to neovascular age-related macular degeneration.
Limon U; Sezgin Akcay BI
Eur J Ophthalmol; 2022 Sep; 32(5):NP32-NP36. PubMed ID: 33781113
[TBL] [Abstract][Full Text] [Related]
12. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
14. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment.
Weinberger AW; Thiel M; Mohammadi B; Theofylaktopoulos I; Thumann G; Walter P
Am J Ophthalmol; 2007 Aug; 144(2):294-6. PubMed ID: 17659961
[TBL] [Abstract][Full Text] [Related]
15. VOLUMETRIC ASSESSMENT OF THE RESPONSIVENESS OF PIGMENT EPITHELIAL DETACHMENTS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION TO INTRAVITREAL BEVACIZUMAB.
Or C; Chui L; Fallah N; Forooghian F
Retina; 2016 Feb; 36(2):264-71. PubMed ID: 26418445
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Change in Pigment Epithelial Detachment Volume and Morphology After Transition to Intravitreal Aflibercept in Eyes With Recalcitrant Neovascular AMD: 18-Month Results.
Kanesa-Thasan A; Grewal DS; Gill MK; Lyon AT; Mirza RG
Ophthalmic Surg Lasers Imaging Retina; 2015 Jun; 46(6):638-41. PubMed ID: 26114844
[TBL] [Abstract][Full Text] [Related]
17. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment.
Clemens CR; Bastian N; Alten F; Milojcic C; Heiduschka P; Eter N
Acta Ophthalmol; 2014 Feb; 92(1):e50-6. PubMed ID: 23819839
[TBL] [Abstract][Full Text] [Related]
18. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration.
Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C
Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal bevacizumab combined with photodynamic therapy for the treatment of occult choroidal neovascularization associated with serous pigment epithelium detachment in age-related macular degeneration.
Ladas ID; Kotsolis AI; Papakostas TD; Rouvas AA; Karagiannis DA; Vergados I
Retina; 2007 Sep; 27(7):891-6. PubMed ID: 17891013
[TBL] [Abstract][Full Text] [Related]
20. The effect of intravitreal anti-VEGF on the pigment epithelial detachment in eyes with the exudative type of age-related macular degeneration.
Kalouda P; Anastasakis A; Tsika C; Tsilimbaris KM
Semin Ophthalmol; 2015 Jan; 30(1):6-10. PubMed ID: 23952911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
